Please find below the latest news from Yourgene Health. We also share this news across social media networks.

17 November 2023 – Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries
Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries
Yourgene’s LightBench instrument offers precise and accurate target enrichment of PacBio HiFi SMRTbell sequencing libraries increasing HiFi sequencing yields
Manchester, UK, 16 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, and PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration to optimise size selection for long-read sequencing workflows. PacBio has qualified Yourgene’s LightBench® instrument for the size selection of long DNA fragments, enabling high yields for HiFi sequencing data.

9 November 2023 – Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco
Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents
Manchester, UK, and Rabat, MOROCCO, 09 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT) workflow in Morocco based on the IONA® test at the Centre de Biologie Riad (Laboriad). By offering this service locally, Laboriad can broaden its offering and provide pregnant women fast, reliable results that reduce the need for invasive tests and the associated stress and anxiety for expectant parents.

7 November 2023 -IVDR certification achieved for DPYD genotyping assay – First product of its kind to conform with new IVDR requirements
IVDR certification achieved for DPYD genotyping assay
First product of its kind to conform with new IVDR requirements
Yourgene Health (part of the Novacyt group), an international specialist in clinical diagnostics, confirms – IVDR accreditation under the new requirements of the In Vitro Diagnostic Regulation (“IVDR”) for its DPYD genotyping assay, which helps identify cancer patients at risk of suffering a severe, and potentially life-threatening, reaction to common chemotherapy.

5 September 2023 – Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows
Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows
Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow
Manchester, UK, and SINGAPORE, 5 September 2023: Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit.

19 June 2023 – Yourgene Health Presents Data Demonstrating Successful Fetal Fraction Enrichment in NIPT Workflows Following Prolonged Blood Storage in EDTA Tubes
The collaborative study with Tommy’s Charity and St Mary’s NHS Hospital (Manchester, UK) used Yourgene’s IONA® Nx NIPT Workflow, a fully validated clinical workflow which utilises NGS to estimate the trisomy risk in the fetus.

22 May 2023 – Directorate Change
Yourgene announces the reappointment of Dr. Joanne Mason, Chief Scientific Officer, as a Director of the Company with immediate effect.

22 May 2023 – Yourgene Genomic Services to support MHC’s Boots agreement
Yourgene has entered into an agreement via its subsidiary Concepta Diagnostics Limited with Boots UK Limited (“Boots”), the health and beauty retailer and pharmacy group, to launch its extended range of at-home self-testing products tests via boots.com and across 120 Boots stores in Great Britain and Northern Ireland.

25 January 2023 – Directorate Change
Andy Leeser is one of the UK’s most experienced mid-market corporate transformation specialists. He has been involved with a range of transformation projects and transactions, including refinancings and equity/ asset sales across the Automotive, Oil and Gas, Brewing, Retail and Telecommunications sectors.

25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Notice of AGM, Change of Registered Address and Investor Presentation Manchester, UK – 25 August 2022: Yourgene (AIM: YGEN), the international molecular diagnostics...

16 August 2022 – Open Day and advance notice of AGM
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Open Day and advance notice of AGM Manchester, UK – 16 August 2022: Yourgene (AIM: YGEN), the international molecular diagnostics group, will be hosting an Open Day at its new facilities on Manchester...

27 July 2022 – Audited Final Results
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Audited Final Results Manchester, UK – 27 July 2022: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces its final results for the financial year ended 31 March...

27 July 2022 – Dr John Brown CBE confirmed as Chairman
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Dr John Brown CBE confirmed as Chairman Manchester, UK – 27 July 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, confirms the appointment of Dr John Brown CBE as Chairman...

24 May 2022 – Launch of the Accelerator Phase for Microdeletions Plugin
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Launch of the Accelerator Phase for Microdeletions Plugin Expanding the clinical menu and capabilities of IONA® Nx NIPT Workflow offering Manchester, UK – 24 May 2022: Yourgene (AIM: YGEN), a...

26 April 2022 – Full year trading update
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Full year trading update Manchester, UK – 26 April 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, provides the following unaudited trading update for the year ended 31...

26 April 2022 – Directorate Change
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Directorate Change Manchester, UK – 26 April 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that after a five-year tenure, Adam Reynolds will step down from...

25 April 2022 – Strategic partnership extended with Ambry Genetics
Yourgene Health plc (“Yourgene” or the “Company”) Strategic partnership extended with Ambry Genetics Expanding market access of technology Manchester, UK – 25 April 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces the Company...

06 April 2022 – Capital Markets Day
Yourgene Health plc (“Yourgene” or the “Company”) Capital Markets Day Manchester, UK – 6 April 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it will be holding a Capital Markets Day for investors on Tuesday 26 April...

17 February 2022 – Successful CTDA desktop review
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Successful CTDA desktop review Approval for sale of Clarigene® SARS-CoV-2 Test in the UK Manchester, UK - 17 February 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostic group,...

25 January 2022 – Directorate Change
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Directorate Change Manchester, UK - 25 January 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces the appointment of Mary Tavener as a Non-executive Director...

19 January 2022 – Opening of new Yourgene Health Canada Inc. facilities
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Opening of new Yourgene Health Canada Inc. facilities Supporting future growth for Ranger® Technology Manchester, UK – 19 January 2022: Yourgene (AIM: YGEN), the international molecular diagnostics...

19 January 2022 – Agreement of new debt facility
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Agreement of new debt facility Silicon Valley Bank facility to provide non-dilutive funding for accretive growth opportunities Manchester, UK – 19 January 2022: Yourgene (AIM: YGEN), a leading...

18 January 2022 – US partnership with EKF Diagnostics for NIPT and additional genomic tests
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) US partnership with EKF Diagnostics for NIPT and additional genomic tests Collaboration with EKF Diagnostics to use its accredited US laboratories for NIPT and Oncology testing Manchester, UK – 18...

17 January 2022 – Current year trading update
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Current year trading update Further upgrade to full year revenue guidance following strong trading performance Manchester, UK – 17 January 2022: Yourgene (AIM: YGEN), the international molecular...

23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DHSC contract awarded to support COVID-19 Winter surge testingThird contract awarded under PHE National Microbiology Framework Agreement Manchester, UK – 23 December 2021: Yourgene (AIM: YGEN), a leading...

14 December 2021 – Half-year Report
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) H1 revenues doubled year-on-yearFull year revenues to exceed already upgraded market expectations Manchester, UK – 14 December 2021: Yourgene (AIM: YGEN), a leading integrated technologies and service...

14 December 2021 – UKHSA contract award
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) UKHSA contract awardContract for the provision of the genetic sequencing services Manchester, UK – 14 December 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces...

18 November 2021 – DPYD screening recommended in Spain
Yourgene Health plc(“Yourgene” or the “Company”) DPYD screening recommended in SpainFollows recommendations in Germany, Wales, England and Belgium Manchester, UK – 18 November 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, welcomes...

28 October 2021 – Yourgene’s Ranger Technology to be presented at Labroots webinar
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene’s Ranger® Technology to be presented at Labroots webinar Manchester, UK – 28 October 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Ranger®...

26 October 2021 – Half-year Trading update
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Trading updateImproved H1 and year-to-date performance supporting higher full-year expectations Manchester, UK – 26 October 2021: Yourgene (AIM: YGEN), a leading international molecular...

19 April 2021 – Further National Microbiology Framework contract award
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Further National Microbiology Framework contract award Successful tender under Lot 4 (Clinical Laboratory Diagnostic Testing Services) valued at £15bn Manchester, UK – 19 April 2021: Yourgene (AIM:...

28 September 2021 – AGM Statement Investor presentation
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) AGM StatementInvestor presentation Manchester, UK - 28 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, will be holding its Annual General Meeting (AGM)...

10 September 2021 – Further re: DHSC contract secured to support COVID-19 surge testing
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Further re: DHSC contract secured to support COVID-19 surge testing Manchester, UK 10 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces that a Contract...

1 September 2021 – Notice of AGM and Annual Report 2021
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Notice of AGM and Annual Report 2021Investor presentation Manchester, UK 1 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces that the Notice of Annual...

1 September 2021 – Yourgene Genomic Services receive ISO 15189:2012 accreditation
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene Genomic Services receive ISO 15189:2012 accreditation Validating its COVID-19 testing and sequencing services, providing assurance of compliance to international standards to deliver quality...

19 August 2021 – Yourgene’s COVID-19 testing investment reaps rewards DHSC contract secured to support COVID-19 surge testing
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene’s COVID-19 testing investment reaps rewardsDHSC contract secured to support COVID-19 surge testing Manchester, UK 19 August 2021: Yourgene (AIM: YGEN), a leading international molecular...

11 August 2021 – Audited Final results and unaudited Q1 business update
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Audited Final results and unaudited Q1 business update Manchester, UK – 11 August 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces its full year financial results for...

11 August 2021 – Earn-out Milestone, Issue of Equity & Total Voting Rights
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Earn-out Milestone, Issue of Equity & Total Voting Rights Manchester, UK 11 August 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces an issue of equity...

21 June 2021 – Second Strategic Partner for Coastal Genomics
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Second Strategic Partner for Coastal Genomics Manchester, UK – 21 June 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that Yourgene Health Inc., the Company’s...

18 June 2021 – Contract Award for the supply of DPYD testing kits to NHS Wales
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Contract Award for the supply of DPYD testing kits to NHS WalesEstimated to be worth £232,000 across two years Manchester, UK – June 2021: Yourgene (AIM: YGEN), the international molecular...

9 June 2021 – Multi-year licence and supply agreement with leading US precision medicine company
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Multi-year licence and supply agreement with leading US precision medicine company Manchester, UK – 9 June 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces it has...

19 May 2021 – Distribution Partnership for the Middle East and Africa
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Distribution Partnership for the Middle East and AfricaYourgene and Alliance Global launch partnership across multiple territories Manchester, UK – 19 May 2021: Yourgene (AIM: YGEN), the international...

18 May 2021 – Launch of IONA® Care NIPT service offering
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Launch of IONA® Care NIPT service offeringExtended clinical menu to screen SCAs and AAs for pregnant women Manchester, UK – 18 May 2021: Yourgene (AIM: YGEN), the international molecular diagnostics...

17 May 2021 – Further testing service agreement for MyHealthChecked plc
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene Genomic Services to support MHC’s second Boots agreement for Day 2 & Day 8 testingfor international arrivals to the UK Manchester, UK – 17 May 2021: Yourgene (AIM: YGEN), the...

24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) COVID-19 update: approved provider for UK Government and response to new virus strain Manchester, UK – 24 December 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group,...

17 December 2020 – Half-year Report
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Report Manchester, UK – 17 December 2020: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces its...

2 December 2020 – DPYD kits recommended by NHS England
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DPYD kits recommended by NHS England Manchester, UK – 2 December 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, welcomes the Clinical Commissioning Urgent Policy Statement,...

5 November 2020 – Directorate change
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Directorate changeChief Scientific Officer appointment to drive new product development roadmap Manchester, UK – 5 November 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group,...

3 November 2020 – Partnership with Take2 Health Limited
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Partnership with Take2 Health LimitedYourgene to run genomic test for Nasopharyngeal Carcinoma (NPC) Screening in Taiwan Manchester, UK – 3 November 2020: Yourgene (AIM: YGEN), the international...

26 October 2020 – Half-year Trading update
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Trading updateH1 year-on-year growth demonstrating the resilience of the Company Manchester, UK – 26 October 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group,...

23 October 2020 – CQC registration
Yourgene Health plc(“Yourgene Health” or the "Company") CQC registration Manchester, UK – 23 October 2020: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces that it has received notification from the Care Quality Commission...

21 October 2020 – Yourgene Genomic Services collaboration with Cytox
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene Genomic Services collaboration with Cytox Partnership with Cytox to enable clinical access to genoSCORE™ - a new genetic test to determine the risk of developing Alzheimer’s disease Manchester,...

14 February 2020 – Medilink Award win for Outstanding Achievement
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Medilink Award win for Outstanding Achievement Manchester, UK – 14 February 2020:Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has won the Outstanding...

12 October 2020 – Elucigene DPYD tests to be used routinely in Wales
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Elucigene DPYD tests to be used routinely in Wales Wales is first UK nation to offer DPYD screening to patients undergoing chemotherapyDPYD tests screen patients to identify risk of severe side effects...

8 October 2020 – Strategic reproductive health partnership secured in Japan
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Strategic reproductive health partnership secured in Japan Manchester, UK – 8 October 2020: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces it has entered into...

7 October 2020 – IONA® Nx awarded contract with St George’s NHS Hospital
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) IONA® Nx awarded contract with St George’s NHS Hospital Manchester, UK – 7 October 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that it has been awarded the...

3 August 2020 – CE-IVD Mark for Clarigene™ SARS-CoV-2 test
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) CE-IVD Mark for Clarigene™ SARS-CoV-2 test Manchester, UK – 3 August 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has achieved CE-IVD marking for its...

28 September 2020 – Launch of Yourgene Genomic Services
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Launch of Yourgene Genomic Services Manchester, UK – 28 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces the launch of Yourgene Genomic Services, an...

24 September 2020 – DPD reimbursement in Germany
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DPD reimbursement in Germany Manchester, UK – 24 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that the German Federal Joint Committee, G-BA, the national...

22 September 2020 – AGM statement
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) AGM Statement Manchester, UK – 22 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, will be holding its Annual General Meeting (AGM) at 4:00pm today. At the meeting,...

21 September 2020 – US distribution agreement for DPYD and other products
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) US distribution agreement for DPYD and other products Manchester, UK – 21 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that it has appointed...

3 September 2020 – IONA® Nx Launch
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) IONA® Nx Launch Manchester, UK – 3 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces the launch of IONA® Nx NIPT workflow, the Company’s new innovative...

13 August 2020 – TGA approves IONA® Nx for sale in Australia
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) TGA approves IONA® Nx for sale in Australia Manchester, UK – 13 August 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that its IONA® Nx NIPT workflow (‘IONA®...

5 August 2020 – Successful £16.15 million Placing & Close of Accelerated Bookbuild
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Successful £16.15 million Placing & Close of Accelerated Bookbuild Manchester, UK – 5 August 2020: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group, is pleased to...

2 December 2019 – Half-year Report
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Yourgene Health plc (“Yourgene”, the “Company” or the “Group”) Half-year Report Manchester, UK – 2 December 2019: Yourgene Health plc (AIM:...

29 November 2019 – Bionow Double Award Wins
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Bionow Double Award Wins Manchester, UK – 29 November 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has won Bionow Investment Deal of Year and Bionow...

28 November 2019 – Opening of New Facilities and Corporate HQ
Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Opening of New Facilities and Corporate HQ Manchester, UK – 28 November 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces the official opening of its...

31 October 2019 – Launch of Yourgene Flex™ Analysis Software
Yourgene Health plc(“Yourgene” or the “Group” or the “Company”) Launch of Yourgene Flex™ Analysis Software Manchester, UK 31 October 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has launched Yourgene Flex™ Analysis...

15 October 2019 – American Society of Human Genetics Annual Meeting attendance
Yourgene Health plc (“Yourgene” or the “Group”) American Society of Human Genetics Annual Meeting attendance Manchester, UK – 15 October 2019:Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it will be exhibiting at the...

14 October 2019 – Half year trading update
Yourgene Health plc (“Yourgene” or the “Group”) Half year trading update Manchester, UK – 14 October 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, provides a positive trading update for the six months to 30 September 2019....

26 September 2019 – CE-IVD Certification renewal
CE-IVD Certification renewal Manchester, UK – 26 September 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that in preparation for a 2020 product launch and as a contingency for BREXIT, the Company has successfully...

18 September 2019 – Launch of DPYD chemotoxicity diagnostic assay
Yourgene Health plc (“Yourgene” or the “Company”) Launch of DPYD chemotoxicity diagnostic assay Test to identify cancer patients at risk of lethal side effects from chemotherapy Manchester, UK – 18 September 2019: Yourgene (AIM: YGEN), a leading international...

20 August 2019 – Notice of AGM
Yourgene Health plc (“Yourgene” or the “Company”) Notice of AGM Manchester, UK – 20 August 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Annual General Meeting (AGM) will be held at 4:00pm on 17 September 2019 at...

16 August 2019 – Directorate Change Appointment of business development sector specialist as Non-executive Director
Yourgene Health plc (“Yourgene” or the “Company”) Directorate Change Appointment of business development sector specialist as Non-executive Director Manchester, UK – 16 August 2019:Yourgene (AIM: YGEN), a leading international molecular diagnostics group,...

29 July 2019 – Appointment of Director
Yourgene Health plc (“Yourgene”, the “Company” or the “Group”) Appointment of Director Manchester, UK – 29 July 2019: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces the...

10 July 2019 – Results for the Year Ended 31 March 2019, Business Update and Director Change
Yourgene Health plc (“Yourgene” or the “Company” or the “Group”) Results for the Year Ended 31 March 2019, Business Update and Director Change Manchester, UK – 10 July 2019: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which...

9 July 2019 – Results for the Year Ended 31 March 2019 Business Update, Director Change
Yourgene Health plc(“Yourgene” or the “Company” or the “Group”) Results for the Year Ended 31 March 2019, Business Update and Director Change Manchester, UK – 10 July 2019: Yourgene Health plc (AIM: YGEN), the international...

24 June 2019 – Yourgene participates in key global conferences
Yourgene Health plc(“Yourgene Health” or the "Company") Yourgene participates in key global conferences Manchester, UK - 24 June 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services,...

25 April 2019 – Completion of Acquisition
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS RESTRICTED AND IS NOT FOR PUBLIC RELEASE, PUBLICATION, OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY...

17 April 2019 – Proposed acquisition of Delta Diagnostics (UK) Limited
Yourgene Health plc(“Yourgene” or the “Company”) Proposed acquisition of Delta Diagnostics (UK) Limited ("Elucigene")andProposed placing of a minimum of 92,682,928new Ordinary SharesandProposed subscription for 4,878,048new Ordinary Shares Highlights ● Proposed...

8 April 2019 – Full-year Trading Update
Yourgene Health plc (“Yourgene”, the “Company” or the “Group”) Full-year Trading Update Manchester, UK – 8 April 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces a trading...

25 March 2019 – Yourgene raises IONA® test awareness in Egypt with British Ambassador (2)
Yourgene Health plc (“Yourgene” or the “Company”) Yourgene raises IONA® test awareness in Egypt with British Ambassador Manchester, UK – 25 March 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and...

18 February 2019 – Yourgene Health Announces Capital and Commercial Restructuring with Major Shareholder
Yourgene Health plc (“Yourgene” or the “Company”) Yourgene Health Announces Capital and Commercial Restructuring with Major Shareholder Manchester, UK – 18 February 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises...

8 January 2019 – High throughput NIPT solution for clinical laboratories
Yourgene Health plc (“Yourgene”, the “Company”) Yourgene launches Sage™ 32 plex High throughput NIPT solution for clinical laboratories Manchester, UK – 8 January 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group...